Final Report: Estimating the Number of Persons co-infected with Hepatitis C Virus and Human Immunodeficiency Virus in Canada

References

1. Archibald CP, Remis RS, Farley J, Sutherland D. Estimating HIV prevalence and incidence at the national level: Combining direct and indirect methods with Monte-Carlo simulation. 12th International Conference on AIDS, Geneva, Switzerland, June-July 1998 (Abstract 43475).

2. Archibald CP, Remis RS, Williams G, et al. Estimating current HIV prevalence and incidence in Canada. Plenary presentation at the 6th Annual Canadian Conference on HIV/AIDS Research, Ottawa, Canada, May 1997.

3. Bureau of HIV/AIDS, STD and TB. National HIV prevalence and incidence estimates for 1999: No evidence of a decline in overall incidence. HIV/AIDS Epi Update. Health Canada, November 2000.

4. Remis RS. Estimating the number of potential beneficiaries of the Canadian HCV Class Action Settlement for persons infected by transfusions from January 1986 to July 1990. Report, July 6, 1999 [Technical report].

5. Remis RS, Palmer RWH. The epidemiology of transfusion-associated HIV infection in Canada, 1978-85. Report to the Laboratory Centre for Disease Control, September 30, 1994.

6. Patrick DM, Strathdee SA, Archibald CP, Ofner M, Craib KJ, Cornelisse PG, Schechter MT, Rekart ML, O'Shaughnessy MV. Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver. Int J STD AIDS 1997 Jul; 8(7):437-45.

7. Strathdee SA, Patrick DM, Currie SL, Cornelisse PG, Rekart ML, Montaner JS, Schechter MT, O'Shaughnessy MV. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 1997 Jul; 11(8):F59-65.

8. Heath KV, Cornelisse PG, Strathdee SA, Palepu A, Miller ML, Schechter MT, O'Shaughnessy MV, Hogg RS. HIV-associated risk factors among young Canadian Aboriginal and non-Aboriginal men who have sex with men. Int J STD AIDS 1999 Sep; 10(9):582-7.

9. Schechter MT, Strathdee SA, Cornelisse PG, Currie S, Patrick DM, Rekart ML, O'Shaughnessy MV Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak. AIDS 1999 Apr 16; 13(6):F45-51.

10. Division of HIV Epidemiology. HIV and AIDS among Aboriginal people in Canada. HIV/AIDS Epi Update. Laboratory Centre for Disease Control, Health Canada, April 2000.

11. Archibald CP, Geduld J. Personal communication, June 2000.

12. Calzavara LM, Major C, Myers T, Schlossberg J, Millson M, Wallace E, Rankin J, Fearon M. The prevalence of HIV-1 infection among inmates in Ontario, Canada.
Can J Public Health 1995 Sep-Oct; 86(5):335-9.

13. Dufour A, Alary M, Poulin C, Allard F, Noel L, Trottier G, Lepine D, Hankins C. Prevalence and risk behaviours for HIV infection among inmates of a provincial prison in Quebec City. AIDS 1996 Aug; 10(9):1009-15.

14. Ford PM, Alifo A, Connop PJ, Panaro L, Zoutman D. Seroprevalence of HIV-1 in a male medium security penitentiary-Ontario. Can Commun Dis Rep 1994 Mar 30; 20(6):45-7.

15. Ford PM, White C, Kaufmann H, MacTavish J, Pearson M, Ford S, Mistry PS, Connop P. Seroprevalence of hepatitis C in a Canadian federal penitentiary for women.
Can Commun Dis Rep 1995 Jul 30;21(14):132-4.

16. Voluntary screening for hepatitis C in a Canadian federal penitentiary for men.

Can Commun Dis Rep 1995 Jul 30;21(14):134-6.

17. Ford PM, White C, Kaufmann H, MacTavish J, Pearson M, Ford S, Sankar-Mistry P, Connop P. Voluntary anonymous linked study of the prevalence of HIV infection and hepatitis C among inmates in a Canadian federal penitentiary for women.Can Med Assoc J 1995 Dec 1; 153(11):1605-9.

18. Ford PM, Pearson M, Sankar-Mistry P, Stevenson T, Bell D, Austin J. HIV, hepatitis C and risk behaviour in a Canadian medium-security federal penitentiary. Queen's University HIV Prison Study Group. QJM 2000 Feb; 93(2):113-9.

19. Hankins C, Gendron S, Richard C, O'Shaughnessy M. HIV-1 infection in a medium security prison for women--Quebec. Can Dis Wkly Rep 1989 Aug 19; 15(33):168-70. Published erratum appears in Can Dis Wkly Rep 1989 Sep 2; 15(35):180.

20. Hankins C, Gendron S, Handley M, Rouah F, O'Shaughnessy M. HIV-1 infection among incarcerated men--Quebec. Can Dis Wkly Rep 1991 Oct 26; 17(43):233-5.

21. Hankins CA, Gendron S, Handley MA, Richard C, Tung MT, O'Shaughnessy M. HIV infection among women in prison: an assessment of risk factors using a nonnominal methodology.Am J Public Health 1994 Oct;84(10):1637-40.

22. Prefontaine RG, Chaudhary RK. Seroepidemiologic study of hepatitis B and C viruses in federal correctional institutions in British Columbia. Can Dis Wkly Rep 1990 Dec 29; 16(52):265-6.

23. Rothon DA, Mathias RG, Schechter MT. Prevalence of HIV infection in provincial prisons in British Columbia. Can Med Assoc J 1994 Sep 15; 151(6):781-7.

24. Bodsworth NJ, Cunningham P, Kaldor J, Donovan B. Hepatitis C virus infection in a large cohort of homosexually active men: Independent associations with HIV-1 infection and injecting drug use but not sexual behaviour. Genitourin Med 1996; 72(2):118-22.

25. Wormser GP, Forseter G, Joline C, Tupper B, O'Brien TA. Hepatitis C in HIV-infected intravenous drug users and homosexual men in suburban New York City. JAMA 1991; 265(22):2958.

26. Ndimbie OK, Kingsley LA, Nedjar S, Rinaldo CR. Hepatitis C virus infection in a male homosexual cohort: Risk factor analysis. Genitourin Med 1996; 72(3):213-6.

27. Francisci D, Baldelli F, Papili R, Stagni G, Pauluzzi S. Prevalence of HBV, HDV and HCV hepatitis markers in HIV-positive patients. Eur J Epidemiol 1995; 11(2):123-6.

28. Corona R, Prignano G, Mele A, Gentili G, Caprilli F, Franco E, Ferrigno L, Giglio A, Titti F, Bruno C, et al. Heterosexual and homosexual transmission of hepatitis C virus: Relation with hepatitis B virus and human immunodeficiency virus type 1. Epidemiol Infect 1991; 107(3):667-72.

29. Sonnerborg A, Abebe A, Strannegard O. Hepatitis C virus infection in individuals with or without human immunodeficiency virus type 1 infection. Infection 1990; 18(6):347-51.

30. Anand CM, Fonseca K, Walle RP, Powell S, Williams M. Antibody to hepatitis C virus in selected groups of a Canadian population. Int J Epidemiol 1992; 21:142-5.

31. Craib K. Personal Communication, March 10, 2000.

32. Crofts N, Jolley D, Kaldor J, van Beek I, Wodak A. Epidemiology of hepatitis C virus infection among injecting drug users in Australia. J Epidemiol Community Health 1997; 51(6):692-7.

33. Crofts N, Hopper JL, Milner R, Breschkin AM, Bowden DS, Locarnini SA. Blood-borne virus infections among Australian injecting drug users: implications for spread of HIV.

Eur J Epidemiol 1994; 10(6):687-94.

34. Santana Rodriguez OE, Male Gil ML, Hernandez Santana JF, Liminana Canal JM, Martin Sanchez AM. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain. Eur J Epidemiol 1998; 14(6):555-61.

35. Coppola RC, Masia G, di Martino ML, Carboni G, Muggianu E, Piro R, Manconi PE. Sexual behaviour and multiple infections in drug users. Eur J Epidemiol 1996; 12:429-35.

36. Thio CL, Nolt KR, Astemborski J, Vlahov D, Nelson KE, Thomas DL. Screening for hepatitis C virus in human immunodeficiency virus-infected individuals. J Clin Microbiol 2000; 38(2):575-7.

37. Weinstock DM, Merrick S, Malak SA, Jacobs J, Sepkowitz KA. Hepatitis C in an urban population infected with the human immunodeficiency virus. AIDS 1999; 13(18):2593-5.

38. Lior L, Stratton E, Archibald CP, et al. Eastern Region Project: Seroprevalence of HIV, HBV, and HCV viruses and high risk behaviours among IDU and sexual partners of IDU. [Slide presentation].

39. Siushanian J, Vooght M, Archibald CP, et al. The Prince Albert Seroprevalence Study. [Slide presentation].

40. Allain JP, Hodges W, Einstein MH, Geisler J, Neilly C, Delaney S, Hodges B, Lee H. Antibody to HIV-1, HTLV-I, and HCV in three populations of rural Haitians.
J Acquir Immune Defic Syndr 1992; 5(12):1230-6.

41. Quaranta JF, Delaney SR, Alleman S, Cassuto JP, Dellamonica P, Allain JP. Prevalence of antibody to hepatitis C virus (HCV) in HIV-1-infected patients (nice SEROCO cohort). J Med Virol 1994; 42(1):29-32.

42. Dorrucci M, Pezzotti P, Phillips AN, Lepri AC, Rezza G. Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS. Italian Seroconversion Study. J Infect Dis 1995; 172(6):1503-8.

43. Ockenga J, Tillmann HL, Trautwein C, Stoll M, Manns MP, Schmidt RE. Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value. J Hepatol 1997; 27(1):18-24.

44. Brenner B, Back D, Ben-Porath E, Hazani A, Martinowitz, Tatrasky I. Coinfection with hepatitis viruses and human immunodeficiency virus in multiply transfused patients.

Israeli J Med Sci 1994; 30:886-90.

45. Pallas J, Farinas-Alvarez C, Prieto D, Llorca J, Delgado-Rodriguez M. Risk factors for monoinfections and coinfections with HIV, hepatitis B and hepatitis C viruses in northern Spanish prisoners. Epidemiol Infect 1999; 123(1):95-102.

46. Pallas JR, Farinas-Alvarez C, Prieto D, Delgado-Rodriguez M. Coinfections by HIV, hepatitis B and hepatitis C in imprisoned injecting drug users. Eur J Epidemiol 1999; 15(8):699-704.

47. Ford PM, White C, Kaufmann H, et al. Voluntary anonymous linked study of the prevalence of HIV infection and hepatitis C among inmates in a Canadian federal penitentiary for women. Can Med Assoc J 1995; 153:1605-9.

48. Prefontaine RG, Chaudhary RK. Seroepidemiologic study of hepatitis B and C viruses in federal correctional institutions in Brirtish Columbia. Can Dis Wkly Rep 1990; 16:265-8.

49. Remis RS, Hogg RS, Krahn MD, Preiksaitis JK, Sherman M. Estimating the number of blood transfusion recipients infected by hepatitis C in Canada, 1960-85 and 1990-92. Report to the Laboratory Centre for Disease Control, June 1998

50. Remis RS, Leclerc P, Routledge R, Millson P, Strathdee S, Palmer R, Degani N, Hogg RS, Bruneau J. Consortium to characterize injection drug use in Canada, March 1998 [Technical Report].

51. Armstrong C, Correctional Service Canada. Personal communication, May 2000.

52. Strike C, Sutherland D. HIV studies among inmates in Canadian prisons: A review.

Can Commun Dis Rep 1994 Mar 30;20(6):47-9.

53. Bird AG, Gore SM, Cameron S, Ross AJ, Goldberg DJ. Anonymous HIV surveillance with risk factor elicitation at Scotland's largest prison, Barlinnie. AIDS 1995 Jul; 9(7):801-8.

54. Gaughwin MD, Douglas RM, Liew C, Davies L, Mylvaganam A, Treffke H, Edwards J, Ali R. HIV prevalence and risk behaviours for HIV transmission in South Australian prisons. AIDS 1991; 5(7): 845-51.

55. Division of HIV Epidemiology. HIV testing among Canadians: 15,000 current HIV infections may not be diagnosed. HIV/AIDS Epi Update. Laboratory Centre for Disease Control, Health Canada, April 2000.

Back